Mark Hancock sells PACS shares (PACS) — three trades in June 2026
Rhea-AI Filing Summary
PACS reported insider sales by Mark Hancock via a Form 144 filing: 153,254 shares sold on 06/15/2026, 83,066 shares sold on 06/16/2026, and 63,680 shares sold on 06/17/2026. The transactions are listed as Common stock dispositions with cash consideration.
Positive
- None.
Negative
- None.
Insights
Form 144 records reported sales by an affiliated holder over three days.
The filing lists three separate Common stock dispositions by Mark Hancock on 06/15/2026, 06/16/2026, and 06/17/2026, with specific share counts provided. The entries identify the transactions as sales for cash.
These entries are procedural disclosures required for restricted or control stock sales; further detail on whether sales were pursuant to a Rule 10b5-1 plan or other arrangement is not included in the provided excerpt.
Three-day insider selling pattern is visible; magnitude is explicit per date.
The filing lists 153,254, 83,066, and 63,680 shares sold on consecutive dates in mid-June 2026. Each row ties a sale to a cash consideration amount shown in the excerpt.
Cash‑flow treatment and post‑transaction holdings are not shown in the excerpt; subsequent filings would provide position context.
Key Figures
Key Terms
Form 144 regulatory
issuer financial
FAQ
What insider transactions did PACS disclose in this Form 144?
Who is the reporting person in the PACS Form 144 filing?
Does the Form 144 excerpt state proceeds or dollar amounts for each sale?
Do we know if these sales were made under a trading plan (e.g., Rule 10b5-1)?
AI-generated analysis. How Rhea-AI works. Not financial advice.